Predictive model to assess risk for cardiac allograft vasculopathy: An intravascular ultrasound study

Journal of the American College of Cardiology

Volumn 26, Issue 6, 1995, Pages 1537-1544

  Mehra, Mandeep R ^a   Ventura, Hector O ^a   Chambers, Richard ^a   Collins, Tyrone J ^a   Ramee, Stephen R ^a   Kates, Marc A ^a   Smart, Frank W ^a   Stapleton, Dwight D ^a  

^a OCHSNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; OKT 3; THYMOCYTE ANTIBODY;

ACCURACY; ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; COMPUTER MODEL; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ULTRASOUND; VASCULAR DISEASE;

ADULT; AGED; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY VESSELS; DEATH, SUDDEN, CARDIAC; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSION; LOGISTIC MODELS; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA;

EID: 0028802205     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00357-6     Document Type: Article

References (40)

1. Development of coronary artery disease in cardiac transplant recipients receiving immunosuppressive therapy with cyclosporine and prednisone
2. Histopathology of graft coronary disease
3. The spectrum of coronary artery pathology in human cardiac allografts
4. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of “angiographically silent” intimal thickening
5. Coronary artery imaging with intravascular ultrasound in patients following cardiac transplantation
6. Assessment of intracoronary morphology in cardiac transplant recipients by angioscopy and intravascular ultrasound
7. Presence of severe intimal thickening by intravascular ultrasound predicts cardiac events in cardiac allograft vasculopathy
8. The pathogenesis of atherosclerosis-an update
9. Immunopathology of coronary atherosclerosis in transplanted hearts
10. Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidemia
11. Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease
12. Post transplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts
13. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and non-immunologic risk factors
14. Influence of donor and recipient gender on cardiac allograft vasculopathy
15. Complications in long-term survivors of cardiac transplantation
16. Risk factor analysis for the major hazards following heart transplantation—rejection, infection, and coronary occlusive disease
17. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis
18. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection
19. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility
20. Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis
21. Vascular rejection and its relationship to allograft coronary artery disease
22. The relationship of soluble interleukin-2 receptor levels to allograft arteriopathy after heart transplantation
23. The Report of the Fifth Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure (JNC V)
24. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection
25. Transplant coronary disease: nonimmunologic risk factors
26. Epidemiology of triglycerides a view from Framingham
27. Older donor age predicts increased risk for coronary vasculopathy in the year following transplantation serial examination by intravascular ultrasound
28. Relationship of donor age and pre-existing coronary disease by angiography and intracoronary ultrasound to later development of cardiac allograft coronary artery disease
29. Hyperlipidemia following heart transplantation: Natural history and intervention with mevinolin (lovastatin)
30. Frequency of hypercholesterolemia after cardiac transplantation
31. Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations
32. Hyperlipidemia after heart transplantation
33. Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients
34. Effects of cyclosporine on prednisolone metabolism
35. Lipoprotein and hepatic lipase activity and high-density lipoprotein subclasses after cardiac transplantation
36. Two different views of the relationship of hypertriglyceridemia to coronary heart disease
37. The influence of rejection episodes on the development of coronary artery disease after heart transplantation
38. Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation
39. A preliminary study of diltiazem in the prevention of coronary artery disease in heart transplant recipients
40. Morphometric analysis of intracoronary ultrasound: A new method to quantitate transplant coronary disease